You have access
SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
Paul Van Caeseele, for the Canadian Public Health Laboratory Network, Dana Bailey, for the Canadian Society of Clinical Chemists, Sarah E. Forgie, for the Association of Medical Microbiology and Infectious Disease Canada, Tanis C. Dingle, for the Canadian Association for Clinical Microbiology and Infectious Diseases, Mel Krajden and for the COVID-19 Immunity Task Force
Commentary